Incb-053914
Web38 U.S. Code § 5314 - Indebtedness offsets. Subject to subsections (b) and (d) of this section and section 3485 (e) of this title, the Secretary shall (unless the Secretary waives … WebINCB related products. MedChemExpress provides thousands of inhibitors, modulators and agonists with high purity and quality, excellent customer reviews, precise and professional product citations, tech support and prompt delivery.
Incb-053914
Did you know?
WebINCB053914; INCB-053914; INCB 053914.;Unknown Specifications Others Appearance Solid powder Dates Modify: 2024-08-20 Online Inquiry * This product is for research or manufacturing use only. Human use is strictly prohibited. * Please note that we will only send quotations to valid professional email addresses. ... WebUzansertib (INCB053914) is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases with IC50 values of 0.24 nM, 30 nM and 0.12 nM for PIM1, PIM2 and PIM3 respectively in biochemical assays. JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
WebEffects of the selective PI3Kδ inhibitor, INCB050465, on PIM isozyme expression in Pfeiffer DLBCL cells (A). Effects of INCB053914 alone, or in combination with INCB050465, on the in vitro proliferation of Pfeiffer DLBCL cells (B). Effects of INCB053914 alone or in combination with INCB050465 on tumor growth in a DLBCL xenograft model (C); with cytarabine on … WebUzansertib (INCB053914) phosphate is an orally active, ATP-competitive pan- PIM kinase inhibitor with IC50 s of 0.24 nM, 30 nM, 0.12 nM for PIM1, PIM2, PIM3, respectively. …
WebINCB053914 is active as a single agent in the majority of cell lines derived from different hematological malignancies, including MM, AML, DLBCL, MCL and T-ALL, with IC50 … WebSynonyms: INCB 053914, INCB-053914; 2088852-47-3
WebINCB-053914 related products. MedChemExpress provides thousands of inhibitors, modulators and agonists with high purity and quality, excellent customer reviews, precise and professional product citations, tech support and prompt delivery.
WebUpon oral administration, pan-PIM kinase inhibitor INCB053914 binds to and inhibits the activities of the three PIM isoforms, PIM1, PIM2 and PIM3. This prevents phosphorylation … high speed chase happening nowWebINCB053914 INCB-053914 1620012-39-6 INCB053914 (INCB-053914) is a novel potent, and selective ATP-competitive, pan-PIM kinase inhibitor with IC50 of 0.24/30.0/0.12 nM … how many days in a yearly quarterWebINCB053914 is a novel, potent, and selective adenosine triphosphate-competitive pan-PIM kinase inhibitor. In vitro, INCB053914 inhibited proliferation and the phosphorylation of downstream substrates in cell lines from multiple hematologic malignancies. INCB053914, may have therapeutic utility in hematologic malignancies when combined with other … how many days in accounting yearWebUzansertib (INCB053914) is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases with IC50 values of 0.24 nM, 30 nM and 0.12 nM for PIM1, PIM2 and PIM3 … how many days in advance disney diningWebBlue Cross Blue Shield of Massachusetts provides a Summary of Benefits and Coverage (SBC) with online access to the corresponding coverage policy to all of our fully insured … high speed chase houston todayWebOct 1, 2024 · MA Vol. 2, No. 3 Page 1 Identification Requirements for CS . Prescriptions. A pharmacy that dispenses federally designated con-trolled substances (CS) and Schedule … high speed chase in albany oregonWebINCB053914; INCB-053914; INCB 053914.;Unknown. Molecular Formula: C20H16FN7OS. Cat No: I007297: IC50: 300 nM: Storage: 0 - 4°C for short term , or -20°C for long term. Recommended degree::-15: Price: Get quote: We would like to match the lowest price on market if possible. For research use only. Not Intended for Therapeutic Use! how many days in a year on venus